|
Market Closed -
NYSE
00:30:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.62 USD | -3.28% |
|
-5.01% | -28.00% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13.69x | 1.05x | -0.17x | 12.41x | - | 14.79x | 7.35% | 3.48B | |
| -11.55x | 0.6x | 0x | 8.21x | - | 19.77x | 15.86% | 3.03B | |
| Average | 1.07x | 0.82x | -0.08x | 10.31x | 17.28x | 11.61% | 3.26B | ||
| Weighted average by Cap. | 1.94x | 0.84x | -0.09x | 10.45x | 17.11x | 11.31% |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
